Aperio Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Aperio Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,146	Closed	-$1.06M	–	2076
2015 Q1	$1.06M	Buy	6,146 +634	+12%	+$93.1K	0.01%	919
2014 Q4	$634K	Sell	5,512 -451	-8%	-$54.6K	0.01%	1105
2014 Q3	$932K	Buy	5,963 +946	+19%	+$137K	0.01%	890
2014 Q2	$619K	Buy	5,017 +709	+16%	+$78.4K	0.01%	1028
2014 Q1	$446K	Buy	+4,308	New	+$441K	0.01%	1384
2013 Q4	–	Sell	-4,642	Closed	-$370K	–	1383
2013 Q3	$310K	Buy	4,642 +685	+17%	+$47.2K	0.01%	1403
2013 Q2	$262K	Buy	+3,957	New	+$226K	0.01%	1356

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Aperio Group's SLXP Position: Q2 2015 in Review

Aperio Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 6,146 shares — an estimated $1.06M sold.

Aperio Group first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $1.06M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Aperio Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Aperio Group sold 6,146 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.06M.
Aperio Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
Aperio Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.06M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Aperio Group's 13F filing for Q2 2015, filed 29 Jul 2015.